Andrew D Westwell

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Topics

Prostate Cancer

Molecular Docking

Radical Prostatectomy

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

Molecular cancer therapeutics

Turkish journal of pharmaceutical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed M Almehdi, Sameh S M Soliman, Abdel-Nasser A El-Shorbagi, Andrew D Westwell, Rania Hamdy
Design, Synthesis, and Potent Anticancer Activity of Novel Indole-Based Bcl-2 Inhibitors. International journal of molecular sciences 24 (19) (2023)
Jitka Soukupová, Cinzia Bordoni, Daniel J Turnham, William W Yang, Gillian Seaton, Aleksandra Gruca, Rhiannon French, Kok Yung Lee, Athina Varnava, Luke Piggott, Richard W E Clarkson, Andrew D Westwell, Andrea Brancale
The Discovery of a Novel Antimetastatic Bcl3 Inhibitor. Molecular cancer therapeutics 20 (5) (2021)
Rania Hamdy, Arwyn Tomos Jones, Mohamed El-Sadek, Alshaimaa M Hamoda, Sarra B Shakartalla, Zainab M Al Shareef, Sameh S M Soliman, Andrew D Westwell
New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents. International journal of molecular sciences 22 (22) (2021)
Sahar B Kandil, Christopher McGuigan, Andrew D Westwell
Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer. Molecules (Basel, Switzerland) 26 (1) (2020)
Sahar B Kandil, Samuel R Jones, Sonia Smith, Stephen E Hiscox, Andrew D Westwell
Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer. Molecules (Basel, Switzerland) 25 (15) (2020)
Rania Hamdy, Samia A Elseginy, Noha I Ziedan, Mohamed El-Sadek, Elsaid Lashin, Arwyn Tomos Jones, Andrew D Westwell
Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2. International journal of molecular sciences 21 (23) (2020)
Rania Hamdy, Samia A Elseginy, Noha I Ziedan, Arwyn T Jones, Andrew D Westwell
New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2. Molecules (Basel, Switzerland) 24 (7) (2019)
Hanif Shirinzadeh, Sibel Suzen, Nurten Altanlar, Andrew D Westwell
Antimicrobial Activities of New Indole Derivatives Containing 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide. Turkish journal of pharmaceutical sciences 15 (3) (2018)
Dafydd Alwyn Dart, Sahar Kandil, Serena Tommasini-Ghelfi, Gilberto Serrano de Almeida, Charlotte Lynne Bevan, Wenguo Jiang, Andrew D Westwell
Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity In Vitro and Tissue Selectivity In Vivo. Molecular cancer therapeutics 17 (9) (2018)
Sahar B Kandil, Filippo Prencipe, Samuel Jones, Stephen Hiscox, Andrew D Westwell
The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancer. Chemical biology & drug design 91 (1) (2017)